Biomaterials Enhanced Simulation Testing

Discovering predictive data of your product?

Less costs and lead time? Higher clinical relevancy?

More ethical value? Regulatory compliance?

Take them all - with BEST.

Novel solutions for biomaterials, medical devices and products

It is a capital mistake to theorize before one has data
— Sherlock Holmes

BEST progress to-date:

  • The first Seqvera US patent for advanced biomaterials testing method has been granted!

  • Gold Sponsor of 2019 Conference of Scandinavian Biomaterials Society (Långvik, Finland, June 2019)

  • Recent publication (open access) on tailoring of compliance of scaffolds for articular cartilage repair gathers a great impact - exceeding 2,500 views!

  • Agreement with a medical service company in application of BEST for development of therapy of mental disorders

  • Became a partner for COST CA17116 network (2018-2021) for research, regulative and translational work of perinatal derivatives as tissue engineering products

  • Seqvera has confirmed "AA" credit Alfa-rating in Finland (Suomen Asiakastieto Oy)

  • Expanded to the Terkko Health Hub - right in the heart of Helsinki University Central Hospital, Helsinki - the second largest healthcare center in the world, combining 23 hospitals.

  • Sponsored European Orthopaedic Research Society 2017 congress. The event in Munich has gathered over 350 orthopaedic professionals in the famous Ludwig Maximillian University.

  • BEST method has successfully demonstrated benefits in veterinary practice - results presented at European Biomaterials Society congress 2017 in Athens: optimization for the robust yet effective biomaterial scaffold for articular cartilage regeneration! See more stories at BEST Cases

  • Seqvera and Netzsch Gerätebau GmbH (Germany) have entered into cooperation agreement enabling production, adaptation and worldwide supply of the high-precision hardware platforms for BEST